Syensqo successfully launched on Euronext

Syensqo successfully launched on Euronext 

The company starts its journey as one of the largest publicly traded specialty companies in the world, focused on innovation and growth

Brussels, December 11, 2023 - 9:30 CET

Today, Syensqo announces the successful listing of its shares on Euronext Brussels and Euronext Paris under ticker SYENS. After the successful completion of the spin-off from Solvay, the listing marks a historical milestone as the company embarks on an exciting, innovation-driven journey focused on delivering superior growth and value creation.

Syensqo’s unique portfolio of market leading solutions addresses environmental and social challenges, through electrification, lightweighting, connectivity, resource efficiency, serving a healthier quality of life for all.  In addition, Syensqo is at the heart of the transition towards a net-zero economy, which is expected to drive new sources of value and support the company’s long-term growth. 

With more than 13,000 employees and activities spread across the world (with 41% of FY2022 net sales in the Americas, 36% in Asia-Pacific and 23% Europe), Syensqo’s long-term ambition is to be the prime innovation partner for its customers, growing on average at around two times the rate of its main end markets, while further improving its best-in-class margin and returns.  

Upon listing, Syensqo has 105,876,417 ordinary shares in issue, each carrying one voting right. The Syensqo share price started its journey at a value of € 90 at market open (9.00 am CET), which corresponds to a market capitalization of € 9.53 billion.

“We are thrilled to begin our journey on Euronext,” said Dr. Ilham Kadri, CEO. “With SYENS in both our name and ticker, we are now officially launched as a science company, one of the largest publicly traded specialty companies in the world. Born from a rich heritage, vision and track record of science, innovation and disruption, we are uniquely exposed to secular megatrends that will accelerate our long-term growth and are dedicated to having a meaningful impact on our planet. 

With our customers at the heart of everything we do, we are ready to discover and unleash breakthrough technologies that will extend our leadership position and as the benchmark for innovation, we will redefine the boundaries of what is possible in materials and consumer applications.”

Syensqo is expected to be included in major stock market indices such as BEL20, Stoxx Europe 600, MSCI Europe, FTSE Russell, among others, subject to the timing of each individual index review.

Important legal information 

This press release is not a prospectus or other offering document for the purposes of Regulation (EU) 2017/1129 of June 14, 2017 (as amended, the “Prospectus Regulation”) or Regulation (EU) 2017/1129 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018, as amended (the “UK Prospectus Regulation”), and the allocation of shares of Syensqo to Solvay’s shareholders as part of the partial demerger of Solvay is expected to be carried out in circumstances that do not constitute “an offer to the public” within the meaning of the Prospectus Regulation or the UK Prospectus Regulation.

You should read the Prospectus prepared by the Company for purposes of the listing and admission of its shares to trading on the regulated markets of Euronext in Brussels and Paris (the “Admission”). The approval of the Prospectus by the Belgian Financial Services and Markets Authority should not be understood as an endorsement of the shares of the Company to be admitted to trading on the aforementioned regulated markets.

Any potential investor should make their investment solely on the basis of information contained in the Prospectus. Potential investors should read the Prospectus before making an investment decision in order to fully understand the potential risks and rewards associated with the decision to invest in the Company’s shares.

Disclaimer

This press release is for informational purposes only and is not intended to, and does not, constitute an offer or invitation to sell or solicitation of an offer to subscribe for or buy, or an invitation to purchase or subscribe for, any securities of the Company or Solvay, any part of the business or assets described herein, or any other interests or the solicitation of any vote or approval in any jurisdiction in connection with the transactions described herein or otherwise, nor shall there be any sale, issuance or transfer of securities in any jurisdiction in contravention of applicable law. This press release should not be construed in any manner as a recommendation to any reader thereof.

The securities of the Company have not been and will not be registered under the U.S. Securities Act of 1933, as amended, and neither Solvay nor the Company intend to make a public offer of securities in the United States.

The distribution of this press release may be restricted by law in certain jurisdictions and persons into whose possession any document or other information referred to herein comes should inform themselves about and observe any such restriction. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction.

This press release is directed solely to persons in the United Kingdom who (i) have professional experience in matters relating to investments, such persons falling within the definition of “investment professionals” in Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the “Financial Promotion Order”) or (ii) are persons falling within Article 49(2)(a) to (d) of the Financial Promotion Order or (iii) other persons to whom an invitation or inducement to engage in investment activity (within the meaning of Section 21 of the Financial Services and Markets Act 2000) may lawfully be communicated or caused to be communicated, (all such persons together being referred to as “relevant persons”). This press release is directed only to relevant persons and must not be acted on or relied on by persons who are not relevant persons.

No representation or warranty or undertaking, express or implied, is made by the Company, Solvay or any of their affiliates, shareholders, directors, advisors, employees and representatives or any other person as to, and no reliance should be placed upon, the fairness, accuracy, completeness or correctness of the press release or the opinions contained therein or any other statement made or purported to be made in connection with the Company or Solvay, for any purpose whatsoever, including but not limited to any investment considerations. No responsibility, obligation or liability whatsoever, whether arising in tort, contract or otherwise, is or will be accepted by the Company, Solvay or any of their affiliates, shareholders, directors, advisors, employees and any respective representatives or any other person for any loss, cost of damage howsoever arising from any use of the press release, or for information or opinions or for any errors, omissions or misstatements contained therein or otherwise arising in connection therewith. 

About Syensqo 

Syensqo is a science company developing groundbreaking solutions that enhance the way we live, work, travel and play. Inspired by the scientific councils which Ernest Solvay initiated in 1911, we bring great minds together to push the limits of science and innovation for the benefit of our customers, with a diverse, global team of more than 13,000 associates in 30 countries.

Our solutions contribute to safer, cleaner, and more sustainable products found in homes, food and consumer goods, planes, cars, batteries, smart devices and health care applications. Our innovation power enables us to deliver on the ambition of a circular economy and explore breakthrough technologies that advance humanity.

Learn more at www.syensqo.com.

Follow us on LinkedIn @Syensqo

Ce communiqué de presse est également disponible en français.
Dit persbericht is ook in het Nederlands beschikbaar.

Attachment

• 20231211 _Syensqo Euronext Listing